Surgical Innovation最新文献_第5页

A Novel Surgical Approach for Type 2 Mirizzi Syndrome: Based on a Decade of Clinical Experience at a Teaching Hospital. 治疗 2 型米利兹综合征的新手术方法：基于一家教学医院十年的临床经验。

IF 2.2 4区医学

Surgical Innovation Pub Date : 2026-08-01 Epub Date: 2021-03-31 DOI: 10.1177/15533506211006057

Hong W Yu, Guoqiang Zhang, Yingjie Zhang, Wanneng Yan

{"title":"A Novel Surgical Approach for Type 2 Mirizzi Syndrome: Based on a Decade of Clinical Experience at a Teaching Hospital.","authors":"Hong W Yu, Guoqiang Zhang, Yingjie Zhang, Wanneng Yan","doi":"10.1177/15533506211006057","DOIUrl":"10.1177/15533506211006057","url":null,"abstract":"Background. The Mirizzi syndrome (MS) is a rare complication of cholecystolithiasis that is often accompanied by severe inflammation and fibrosis around Calot's triangle. It is difficult to treat Type 2 MS surgically, and the treatment for this condition has not yet been standardized. The data on operative management are limited. The study aimed to review our institutional clinical experience regarding surgery and provide recommendations for treating Type 2 MS. Methods: We conducted a retrospective study on 6 patients with MS who were surgically treated at our institution between January 2010 and December 2019. The classification of MS by McSherry CK, Ferstenberg H, Virshup M. The Mirizzi syndrome: Suggested classification and surgical therapy. Surg Gastroenterol. 1982;1:219-225 was used. Mucosal approach was used to treat Type 2 MS. The parameters for comparison included patient demographics, operative procedures, operation time, blood loss, length of hospital stay, complications, and follow-up. Results: There were 23 patients with MS among 10 386 cholecystectomies in our area. Six patients with Type 2 MS had successful surgery, and the mucosal approach was used. The average operative time was 253.3 ± 32.5 minutes. The average blood loss was 70.0 ± 14.1 mL. The mean postoperative hospital stay was 9.5 ± 3.9 days. There was no postoperative mortality. The most frequent postoperative complications were bile leakage (16.7%), and postoperative intra-abdominal collection (16.7%). The mean postoperative follow-up was 10 months, and all patients are asymptomatic. The mucosal approach may decrease the risk of bile duct injury, biliary tract infection, and blood loss more than other surgical approaches. Conclusion: This study demonstrates that the mucosal approach is an effective surgical procedure for Type 2 MS.","PeriodicalId":22095,"journal":{"name":"Surgical Innovation","volume":" ","pages":"426-429"},"PeriodicalIF":2.2,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25533281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Surgeons' Experiences and Perspectives on Physical Ergonomics: A Need for Innovative Solutions. 外科医生对人体工程学的经验和观点：需要创新的解决方案。

IF 2.2 4区医学

Surgical Innovation Pub Date : 2026-08-01 Epub Date: 2026-01-23 DOI: 10.1177/15533506261420368

Riya Sutariya, Sruthi Kunamneni, Wei Wei Zhang, Katherine Fay, Mazen Al-Mansour, Nisha Narula

{"title":"Surgeons' Experiences and Perspectives on Physical Ergonomics: A Need for Innovative Solutions.","authors":"Riya Sutariya, Sruthi Kunamneni, Wei Wei Zhang, Katherine Fay, Mazen Al-Mansour, Nisha Narula","doi":"10.1177/15533506261420368","DOIUrl":"10.1177/15533506261420368","url":null,"abstract":"BackgroundPain that impacts professional and personal life are prevalent among surgeons due to poor ergonomics. The objective of this study is to determine the attitudes, perceptions, and real-world practices of ergonomics with the ultimate goal of deriving novel solutions.MethodsA survey was distributed to surgical faculty/trainees at a single institution. 43 attendings and 116 trainees were invited to participate. Data on demographics, pain experiences, ergonomic practices and attitudes, and perceived barriers to implementing ergonomic principles were ascertained.ResultsOf surveyed surgeons, 18 attendings and 11 trainees responded. 46.7% of surgeons experienced pain, particularly in the neck and back. Although most respondents made adjustments, challenges such as insufficient training, lack of proper equipment and/or instruments, and resistance from others were frequently encountered or anticipated. Most believed ergonomics improves outcomes and an interest in ergonomic training was noted.ConclusionsMany surgeons experience pain and are interested in improving ergonomics. Addressing barriers to improvement could potentially foster better practices, reduce strain on surgeons, decrease pain and injuries, increase surgeon well-being, and potentially improve patient outcomes. Further studies and innovative solutions are needed to address this problem.","PeriodicalId":22095,"journal":{"name":"Surgical Innovation","volume":" ","pages":"338-346"},"PeriodicalIF":2.2,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146030939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Novel Cannula Crafted From Disposable Syringes for Endoscopic Carpal Tunnel Release in the Treatment of Carpal Tunnel Syndrome. 一种由一次性注射器制成的新型套管用于腕管综合征的内镜下腕管释放。

IF 2.2 4区医学

Surgical Innovation Pub Date : 2026-08-01 Epub Date: 2026-01-22 DOI: 10.1177/15533506261417253

Wen Zheng, Min Zhang, Ling Long Zhao, Peng Li, Bo Yang, Sheng Tao Xiang, Yi Sun, Xue Jun Yu

{"title":"A Novel Cannula Crafted From Disposable Syringes for Endoscopic Carpal Tunnel Release in the Treatment of Carpal Tunnel Syndrome.","authors":"Wen Zheng, Min Zhang, Ling Long Zhao, Peng Li, Bo Yang, Sheng Tao Xiang, Yi Sun, Xue Jun Yu","doi":"10.1177/15533506261417253","DOIUrl":"10.1177/15533506261417253","url":null,"abstract":"ObjectiveThis study aims to assess the feasibility and effectiveness of a disposable sterile syringe-derived cannula for endoscopic carpal tunnel release (ECTR) in the treatment of carpal tunnel syndrome (CTS) and to evaluate the clinical outcomes of this technique in patients undergoing ECTR.MethodsECTR was performed on patients with CTS. A 2.5 mL disposable sterile syringe was modified into a cannula with an upper calibrated section and a transparent lower portion. A skin incision, approximately 1 cm in length, was made on the ulnar side of the palmaris longus tendon at the proximal wrist crease level. Following blunt dissection, the cannula was inserted into the wound, and both the arthroscope and a spade knife were introduced simultaneously. The instruments were advanced with the spade knife cutting the transverse carpal ligament (TCL) from proximal to distal under direct visualization. The wound was closed using silk sutures. All patients were followed for a minimum of 6 months postoperatively. At the final follow-up, the Boston Carpal Tunnel Syndrome Questionnaire's symptom severity score (SSS) and function status score (FSS), along with the visual analogue scale (VAS) for pain, were recorded and compared to preoperative values.ResultsA total of 16 patients (19 wrists) with a mean age of 52.5 years were enrolled between May 2024 and December 2024. All patients completed the follow-up, with a median duration of 8 months. At the final follow-up, VAS scores, SSS-BCTSQ, and FSS-BCTSQ demonstrated significant improvements from baseline (P < 0.001). No intraoperative or postoperative complications were reported.ConclusionThe use of a 2.5 mL disposable sterile syringe to create a cannula for ECTR in CTS treatment is a safe, and feasible approach.","PeriodicalId":22095,"journal":{"name":"Surgical Innovation","volume":" ","pages":"363-370"},"PeriodicalIF":2.2,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146030948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Novel Device for Safe Endovascular Aortic Endograft Explantation. 一种安全的主动脉腔内植入术新装置。

IF 2.2 4区医学

Surgical Innovation Pub Date : 2026-08-01 Epub Date: 2026-01-03 DOI: 10.1177/15533506251414955

Richard Longfei Li, Mohamed A Zayed, J Westley Ohman

{"title":"Novel Device for Safe Endovascular Aortic Endograft Explantation.","authors":"Richard Longfei Li, Mohamed A Zayed, J Westley Ohman","doi":"10.1177/15533506251414955","DOIUrl":"10.1177/15533506251414955","url":null,"abstract":"Background/NeedEndovascular aneurysm repair (EVAR) is widely used for treatment of abdominal aortic aneurysms (AAA), but 1-5% of grafts require explantation due to complications such as endoleak or infection. Current techniques rely on modified non-FDA approved techniques that risk vessel trauma. We have designed and constructed the EVAx device to support the efficient and non-traumatic retrieval of AAA endografts that rely on suprarenal barb fixation.Methodology and Device DescriptionWe designed a single-use, handheld EVAx device for open endograft removal. It features a cylindrical base, diameter-reducing clamp, and variable constraining arms with tapered tips. Activation collapses the graft and disengages suprarenal barb elements. Prototypes were 3D printed and iteratively refined to facilitate future verification and validation testing.Preliminary ResultsBenchtop testing demonstrated successful engagement of the proximal endograft and suprarenal barbs. Endografts were successfully constrained with adequate reduction of the endograft diameter, disengagement of the barbs, and subsequent retrieval.Current StatusEVAx is undergoing further design optimization with high-fidelity bench-top models and preclinical animal testing. Future use will be intended for the efficient and non-traumatic extraction of aortic endografts with suprarenal fixation.","PeriodicalId":22095,"journal":{"name":"Surgical Innovation","volume":" ","pages":"413-416"},"PeriodicalIF":2.2,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145892625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Preclinical Safety Evaluation of the LapBox Power Tissue Containment System Under Simulated Worst-Case Conditions in a Porcine Model. 在猪模型中模拟最坏情况下LapBox动力组织密封系统的临床前安全性评估。

IF 2.2 4区医学

Surgical Innovation Pub Date : 2026-08-01 Epub Date: 2026-01-08 DOI: 10.1177/15533506261415989

Yuval Ramot, Raphael Lioz, Tal Levin-Harrus, Abraham Nyska

{"title":"Preclinical Safety Evaluation of the LapBox Power Tissue Containment System Under Simulated Worst-Case Conditions in a Porcine Model.","authors":"Yuval Ramot, Raphael Lioz, Tal Levin-Harrus, Abraham Nyska","doi":"10.1177/15533506261415989","DOIUrl":"10.1177/15533506261415989","url":null,"abstract":"Background/NeedUncontained power morcellation during laparoscopic gynecologic surgery risks intra-abdominal dissemination of benign or malignant tissue, a significant safety concern highlighted by FDA warnings. This has created a critical need for robust and reliable tissue containment systems that can be easily integrated into surgical workflows to mitigate this risk.Methodology and device descriptionThe LapBox Power Tissue Containment System is a single-use device featuring a dual-walled inflatable chamber designed to create a secure environment for morcellation. We conducted a Good Laboratory Practice (GLP)-compliant toxicology study in three female domestic pigs to assess its safety under simulated worst-case conditions. The device was inserted laparoscopically, and the internal dual-walled chamber of the device was inflated to a high pressure (∼160 mmHg) to simulate a localized worst-case compressive scenario, while the overall intra-abdominal insufflation was maintained at a standard 15 mmHg. Postoperative monitoring included clinical observation, bloodwork, and, at day 13, necropsy and histopathology.Preliminary ResultsAll procedures were completed without mortality, morbidity, or device-related complications. The LapBox maintained full structural integrity. Postoperative clinical, hematological, and biochemical parameters showed no adverse effects. Gross necropsy and detailed histopathology confirmed the absence of device-related ischemia, necrosis, thrombosis, or foreign-body reaction.Current statusThis preclinical study demonstrates that the LapBox Power system has an excellent safety profile and biocompatibility, even under extreme conditions. The device is ready for the next stage of evaluation. These findings support its translational potential and warrant further investigation in human clinical studies to confirm its safety and efficacy.","PeriodicalId":22095,"journal":{"name":"Surgical Innovation","volume":" ","pages":"417-421"},"PeriodicalIF":2.2,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13346599/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Assessment of Dorsal Genital Nerve Stimulation for Fecal Incontinence: A Systematic Review and Meta-Analysis. 生殖背神经刺激治疗大便失禁的评估：系统回顾和荟萃分析。

IF 2.2 4区医学

Surgical Innovation Pub Date : 2026-08-01 Epub Date: 2026-01-08 DOI: 10.1177/15533506261415996

Prokopis Christodoulou, Konstantinos Perivoliotis, Stavros-Chrysovalantis Liapis, Dimitrios Lytras, Ioannis Baloyiannis

{"title":"Assessment of Dorsal Genital Nerve Stimulation for Fecal Incontinence: A Systematic Review and Meta-Analysis.","authors":"Prokopis Christodoulou, Konstantinos Perivoliotis, Stavros-Chrysovalantis Liapis, Dimitrios Lytras, Ioannis Baloyiannis","doi":"10.1177/15533506261415996","DOIUrl":"10.1177/15533506261415996","url":null,"abstract":"BackgroundThe aim of this study was to summarize the current evidence regarding the role of dorsal genital nerve stimulation (DGNS) in the management of fecal incontinence (FI).Patients and MethodsThis study was conducted in accordance with the Cochrane Handbook for Systematic Reviews of Interventions and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A literature search was performed (Medline, Scopus, CENTRAL, Web of Science, CORE, medRxiv Repository, SciELO, AJOL, and Google Scholar) to identify and retrieve the eligible studies. The last search date was 13/12/2025. The primary endpoint was the pooled complication rate of DGNS in patients with FI. Both prospective and retrospective studies were considered. Quality evaluation was performed via the ROBINS-I tool.ResultsOverall, 6 non-randomized studies and 90 patients were included. The overall complication rate was 1.9% (95% CI: -1.1%, 4.9%; I2 = 0%; P = .213). Α post-interventional improvement of the anal resting pressure (MD: 11.6; 95% CI: 6.5, 16.79; I2 = 0%; P < .001) and anal squeeze pressure (MD: 35.3; 95% CI: 17.24, 53.33; I2 = 0%; P < .001) was confirmed. The application of ROBINS-I tool resulted in all studies being graded as high-risk of bias.ConclusionsWe emphasize the need for prospective randomized controlled trials to determine the exact role of DGNS in the management of FI.","PeriodicalId":22095,"journal":{"name":"Surgical Innovation","volume":" ","pages":"403-412"},"PeriodicalIF":2.2,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

AI of the Beholder: How Surgical and Medical Specialties View Intelligent Technology. 旁观者的人工智能：外科和医学专家如何看待智能技术。

IF 2.2 4区医学

Surgical Innovation Pub Date : 2026-08-01 Epub Date: 2026-01-13 DOI: 10.1177/15533506251413069

Daniel Schneider, Ethan D L Brown, Timothy G White, Jung Park, Max Ward, Aladine A Elsamadicy, Daniel M Sciubba, Sheng-Fu Larry Lo

{"title":"AI of the Beholder: How Surgical and Medical Specialties View Intelligent Technology.","authors":"Daniel Schneider, Ethan D L Brown, Timothy G White, Jung Park, Max Ward, Aladine A Elsamadicy, Daniel M Sciubba, Sheng-Fu Larry Lo","doi":"10.1177/15533506251413069","DOIUrl":"10.1177/15533506251413069","url":null,"abstract":"BackgroundHow clinicians conceptualize artificial intelligence reveals underlying assumptions about professional authority and decision-making. This study examined whether surgical and medical specialties frame AI differently in research and if such differences reflect divergent professional norms.Methods1561 AI-related research abstracts published between January 1, 2019, and March 27, 2025, in 30 high-impact journals. Abstracts were identified through a structured PubMed query and analyzed using a large language model (DeepSeek Reasoner) trained to classify along three dimensions: the human-AI relationship, the impact on professional autonomy, and the locus of decision control. A stratified validation sample was independently coded by a human rater. Chi-square testing and logistic regression were used to assess differences by specialty and publication year.ResultsSurgical abstracts more frequently framed AI as assistive (69.8% vs 54.9%; P < .001), explicitly addressed professional autonomy (73.5% vs 61.3%; P < .001), and specified decision control (69.3% vs 58.6%; P < .001) compared to medical abstracts. These differences persisted across the 7-year period. In multivariable logistic regression, assistive framing (OR, 2.43; 95% CI, 1.82-3.23) and explicit autonomy discussion (OR, 1.46; 95% CI, 1.11-1.92) were independently associated with surgical specialty.ConclusionsSurgical and medical specialties exhibit distinct patterns in how they conceptualize AI, reflecting established perspectives on authority, expertise, and the human-machine relationship. These framings have implications for AI tool design, clinical implementation, and healthcare governance. Recognizing conceptual differences on AI is critical as healthcare transitions toward algorithmically mediated decision-making, as they may shape the future culture of clinical care.","PeriodicalId":22095,"journal":{"name":"Surgical Innovation","volume":" ","pages":"355-362"},"PeriodicalIF":2.2,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145965694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Custom 3D-Printed Supports for Intraoperative Positioning in Endocrine Surgery: A Technical Report. 定制3d打印支架用于内分泌外科术中定位：技术报告。

IF 2.2 4区医学

Surgical Innovation Pub Date : 2026-08-01 Epub Date: 2026-01-21 DOI: 10.1177/15533506261420370

Yong Joon Suh

{"title":"Custom 3D-Printed Supports for Intraoperative Positioning in Endocrine Surgery: A Technical Report.","authors":"Yong Joon Suh","doi":"10.1177/15533506261420370","DOIUrl":"10.1177/15533506261420370","url":null,"abstract":"BackgroundCustomizable positioning devices for endocrine surgery are scarce, and existing solutions often rely on improvised supports. This technical report introduces 3 patented 3D-printed devices developed to enhance precision, ergonomics, and safety during endocrine procedures.Methodology and Device DescriptionThe required devices were designed using available software and printed via Fused Deposition Modeling with ABS filament. Post-processing involved acetone smoothing and the addition of an EVA lining for enhanced patient comfort. Specifically, a 3D-printed neck pillow and arm sling were applied during thyroidectomy, while a 3D-printed prone mattress was utilized for adrenalectomy. These devices incorporated modular cushions and magnetic fasteners to facilitate rapid assembly.Preliminary ResultsThe thyroid surgery yielded optimal neck extension, a 73-minute operative time, and 50 mL blood loss without complication. Adrenal surgery was completed with a 105-minute operative time and 50 mL of blood loss, followed by an uneventful recovery. Both patients were discharged on postoperative day 2. The surgical devices allowed stable intraoperative positioning in the reported cases, without observed positioning-related adverse events.Current StatusThese lightweight, modular 3D-printed devices were designed to support ergonomic and stable positioning in endocrine procedures. Despite their preliminary success, broader adoption will require addressing challenges related to cost, regulation, and process integration.","PeriodicalId":22095,"journal":{"name":"Surgical Innovation","volume":" ","pages":"422-425"},"PeriodicalIF":2.2,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146019078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Responsible Off-Label Device Use in Surgical Innovation: A Review and LABEL Framework. 外科创新中负责任的标签外器械使用：回顾和标签框架。

IF 2.2 4区医学

Surgical Innovation Pub Date : 2026-07-30 DOI: 10.1177/15533506261475904

Vishal G Shelat

{"title":"Responsible Off-Label Device Use in Surgical Innovation: A Review and LABEL Framework.","authors":"Vishal G Shelat","doi":"10.1177/15533506261475904","DOIUrl":"10.1177/15533506261475904","url":null,"abstract":"Background: Off-label and Instructions-for-Use (IFU)-silent medical-device use is common in surgery. Such use is not inherently unsafe, unethical, or unlawful. However, it raises important questions about evidence, consent, professional judgement, documentation, adverse-event reporting, and institutional governance.Methods: A review and critical synthesis of literature on off-label medical-device use, IFU-discordant use, physician-directed device use, and selected device examples relevant to general surgery was performed. Regulatory guidance from global agencies, professional statements, prior reviews, selected legal and governance literature, and device-specific surgical literature was reviewed.Statistics: No meta-analysis was performed because the included literature was heterogeneous in device type, anatomical context, regulatory status, study design, and outcomes. Findings were synthesized descriptively.Results: The literature fell into three groups: regulatory and professional guidance; previous reviews and specialty statements; and device-specific surgical literature. A practical taxonomy for off-label, IFU-silent use, modified use, reuse/reprocessing, expired-device use, and repurposing is summarised. We integrated off-label and IFU-silent device use with ethics, professionalism, consent, patient safety, adverse-event reporting, and governance. We propose the LABEL framework: Label, Alternatives, Basis, Explain, and Log/Learn.Conclusion: Responsible off-label device use requires transparency and accountability. Sound judgement, evidence, patient-specific reasoning, consent, documentation, and audit remain professional obligations, and the LABEL framework provides a practical guide.","PeriodicalId":22095,"journal":{"name":"Surgical Innovation","volume":" ","pages":"15533506261475904"},"PeriodicalIF":2.2,"publicationDate":"2026-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148631556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Coatings on Absorbable Meshes Used for Hernia Repair: A Scoping Review. 用于疝修补的可吸收网涂层：范围综述。

IF 2.2 4区医学

Surgical Innovation Pub Date : 2026-07-30 DOI: 10.1177/15533506261473957

Sophus Hvidt, Jacob Rosenberg, Jason Joe Baker

{"title":"Coatings on Absorbable Meshes Used for Hernia Repair: A Scoping Review.","authors":"Sophus Hvidt, Jacob Rosenberg, Jason Joe Baker","doi":"10.1177/15533506261473957","DOIUrl":"https://doi.org/10.1177/15533506261473957","url":null,"abstract":"IntroductionPermanent meshes are used to reduce recurrences in abdominal hernia repair, yet recurrence rates remain high, and permanent meshes may be associated with chronic pain. Absorbable meshes may reduce mesh-related complications but are associated with an increased recurrence risk. Mesh coatings may improve biocompatibility and outcomes. We aimed to provide an overview of coatings applied to absorbable meshes and to report beneficial and adverse effects.MethodsAll studies including humans or animals investigating non-commercially coated absorbable meshes in abdominal hernia repair were included. PubMed, Embase, Cochrane Central, LILACS, and CNKI were searched without language constraints.ResultsOf 3409 studies screened, 46 were included. All were conducted on animals (n = 1641) with surgically induced hernias. Median follow-up was 45 days (range 14-252). The 22 studied coatings were mesenchymal stem cells, platelet-rich plasma, different growth factors, fibroblasts, amniotic fluid, amniotic membrane, skeletal muscle cells, fibrinogen, zinc and citric acid, extracellular matrix, chitosan and/or ibuprofen, ibuprofen, dexamethasone, licorice extract, Royal Jelly honey, astragalus extract, silk fibroin, alginate, cyclic arginine-glycine-aspartic acid peptide, and CuSO4 (copper). Mesenchymal stem cells and platelet-rich plasma were most studied. Mesenchymal stem cells and platelet-rich plasma increased cell ingrowth, collagen deposition, neovascularization, and increased tensile strength, while reducing inflammation; however, platelet-rich plasma showed variable effects on inflammation. In addition, platelet-rich plasma reduced recurrences.ConclusionWe identified 22 different coatings used on absorbable meshes, with variable results. Mesenchymal stem cells and platelet-rich plasma were most studied, the latter with promising preclinical findings on recurrence reduction, requiring clinical confirmation.","PeriodicalId":22095,"journal":{"name":"Surgical Innovation","volume":" ","pages":"15533506261473957"},"PeriodicalIF":2.2,"publicationDate":"2026-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148631583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0